Lidocaine Patch 5% Available from Mylan
Mylan Lidocaine Patch 5%
Intended for U.S. healthcare professionals only.

Post-herpetic Neuralgia (PHN)

Post-herpetic neuralgia (PHN)—persistence of the pain of herpes zoster for more than 3 months after resolution of the rash—is the most common chronic complication of herpes zoster.1,2 Approximately 20% of herpes zoster patients report some pain at 3 months after the onset of symptoms, and 15% report pain at 2 years.2  

According to the Centers for Disease Control and Prevention:

  • People with PHN have severe pain in the areas where they had the shingles rash, even after the rash clears up3
  • The pain from PHN may be severe, but it usually resolves in a few weeks or months in most patients3
  • As people get older, they are more likely to develop PHN, and the pain is more likely to be severe3
  • PHN occurs rarely among people under 40 years of age but can occur in up to a third of untreated people who are 60 years of age and older3

Common dermatomes of shingles

Shingles is a painful rash that usually develops on one side of the face or body. The shingles rash forms blisters that typically scab over in 7 to 10 days and clears up within 2 to 4 weeks.4

Before the rash develops, people often have pain, itching or tingling in the area where the rash will develop. This may happen anywhere from 1 to 5 days before the rash appears.4
Post-herpetic neuralgia (PHN) treatment and after-shingles pain

  • The shingles rash most commonly appears on the trunk along a thoracic dermatome, in a single stripe around either the left or right side of the body.
INDICATION

Lidocaine patch 5% is indicated for relief of pain associated with post-herpetic neuralgia. Apply only to intact skin.

IMPORTANT SAFETY INFORMATION

Lidocaine patch 5% is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product.

Even a used lidocaine patch 5% contains a large amount of lidocaine (at least 115 mg). The potential exists for a small child or a pet to suffer serious adverse effects from chewing or ingesting a new or used lidocaine patch 5%, although the risk with this formulation has not been evaluated. It is important for patients to store and dispose of lidocaine patch 5% out of the reach of children, pets and others.

Excessive dosing by applying lidocaine patch 5% to larger areas or for longer than the recommended wearing time could result in increased absorption of lidocaine and high blood concentrations, leading to serious adverse effects.

Patients with severe hepatic disease are at greater risk of developing toxic blood concentrations of lidocaine, because of their inability to metabolize lidocaine normally.

Patients allergic to para-aminobenzoic acid derivatives (procaine, tetracaine, benzocaine, etc.) have not shown cross sensitivity to lidocaine. However, lidocaine patch 5% should be used with caution in patients with a history of drug sensitivities, especially if the etiologic agent is uncertain.

Application to broken or inflamed skin, although not tested, may result in higher blood concentrations of lidocaine from increased absorption. Lidocaine patch 5% is only recommended for use on intact skin.

Placement of external heat sources, such as heating pads or electric blankets, over lidocaine patch 5% patches is not recommended as this has not been evaluated and may increase plasma lidocaine levels.

The contact of lidocaine patch 5% with eyes, although not studied, should be avoided based on the findings of severe eye irritation with the use of similar products in animals. If eye contact occurs, immediately wash out the eye with water or saline and protect the eye until sensation returns.

Patients should wash their hands after handling of lidocaine patch 5%.

Lidocaine patch 5% should be used with caution in patients receiving Class I antiarrhythmic drugs (such as tocainide and mexiletine) since the toxic effects are additive and potentially synergistic.

When lidocaine patch 5% is used concomitantly with other products containing local anesthetic agents, the amount absorbed from all formulations must be considered.

Lidocaine patch 5% may not stick if it gets wet. Avoid contact with water, such as bathing, swimming or showering.

Lidocaine patch 5% should be used with caution in pregnant (including labor and delivery) or nursing mothers.

During or immediately after treatment with lidocaine patch 5%, the skin at the site of application may develop blisters, bruising, burning sensation, depigmentation, dermatitis, discoloration, edema, erythema, exfoliation, irritation, papules, petechia, pruritus, vesicles, or may be the locus of abnormal sensation. These reactions are generally mild and transient, resolving spontaneously within a few minutes to hours. Other reactions may include dizziness, headache, and nausea.

Allergic and anaphylactoid reactions associated with lidocaine, although rare, can occur. They are characterized by angioedema, bronchospasm, dermatitis, dyspnea, hypersensitivity, laryngospasm, pruritus, shock, and urticaria. If they occur, they should be managed by conventional means.

Discard used patches by folding used patch so that the adhesive side sticks to itself and safely discard used patches or pieces of cut patches where children and pets cannot get to them.


Click here for full Prescribing Information for Mylan Lidocaine Patch 5%.

IMPORTANT SAFETY INFORMATION AND INDICATION

SEE MORE SEE LESS

Lidocaine patch 5% is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product.

Even a used lidocaine patch 5% contains a large amount of lidocaine (at least 115 mg). The potential exists for a small child or a pet to suffer serious adverse effects from chewing or ingesting a new or used lidocaine patch 5%, although the risk with this formulation has not been evaluated. It is important for patients to store and dispose of lidocaine patch 5% out of the reach of children, pets and others.

Excessive dosing by applying lidocaine patch 5% to larger areas or for longer than the recommended wearing time could result in increased absorption of lidocaine and high blood concentrations, leading to serious adverse effects.

Patients with severe hepatic disease are at greater risk of developing toxic blood concentrations of lidocaine, because of their inability to metabolize lidocaine normally.

Patients allergic to para-aminobenzoic acid derivatives (procaine, tetracaine, benzocaine, etc.) have not shown cross sensitivity to lidocaine. However, lidocaine patch 5% should be used with caution in patients with a history of drug sensitivities, especially if the etiologic agent is uncertain.

Application to broken or inflamed skin, although not tested, may result in higher blood concentrations of lidocaine from increased absorption. Lidocaine patch 5% is only recommended for use on intact skin.

Placement of external heat sources, such as heating pads or electric blankets, over lidocaine patch 5% patches is not recommended as this has not been evaluated and may increase plasma lidocaine levels.

The contact of lidocaine patch 5% with eyes, although not studied, should be avoided based on the findings of severe eye irritation with the use of similar products in animals. If eye contact occurs, immediately wash out the eye with water or saline and protect the eye until sensation returns.

Patients should wash their hands after handling of lidocaine patch 5%.

Lidocaine patch 5% should be used with caution in patients receiving Class I antiarrhythmic drugs (such as tocainide and mexiletine) since the toxic effects are additive and potentially synergistic.

When lidocaine patch 5% is used concomitantly with other products containing local anesthetic agents, the amount absorbed from all formulations must be considered.

Lidocaine patch 5% may not stick if it gets wet. Avoid contact with water, such as bathing, swimming or showering. 

Lidocaine patch 5% should be used with caution in pregnant (including labor and delivery) or nursing mothers.

During or immediately after treatment with lidocaine patch 5%, the skin at the site of application may develop blisters, bruising, burning sensation, depigmentation, dermatitis, discoloration, edema, erythema, exfoliation, irritation, papules, petechia, pruritus, vesicles, or may be the locus of abnormal sensation. These reactions are generally mild and transient, resolving spontaneously within a few minutes to hours. Other reactions may include dizziness, headache, and nausea.

Allergic and anaphylactoid reactions associated with lidocaine, although rare, can occur. They are characterized by angioedema, bronchospasm, dermatitis, dyspnea, hypersensitivity, laryngospasm, pruritus, shock, and urticaria. If they occur, they should be managed by conventional means.

Discard used patches by folding used patch so that the adhesive side sticks to itself and safely discard used patches or pieces of cut patches where children and pets cannot get to them.

INDICATION

Lidocaine patch 5% is indicated for relief of pain associated with post-herpetic neuralgia. Apply only to intact skin.